Evidence against dopamine as the mediator of the rise of cyclic AMP in the superior cervical ganglion of the rat

Evidence against dopamine as the mediator of the rise of cyclic AMP in the superior cervical ganglion of the rat

Vol. 65, No. 2, 1975 BIOCHEMICALAND BIOPHYSICAL RESEARCH COMMUNICATIONS EVIDENCE AGAINST DOPAMINE AS THE MEDIATOR OF THE RISE OF CYCLIC AMP IN THE S...

326KB Sizes 5 Downloads 48 Views

Vol. 65, No. 2, 1975

BIOCHEMICALAND BIOPHYSICAL RESEARCH COMMUNICATIONS

EVIDENCE AGAINST DOPAMINE AS THE MEDIATOR OF THE RISE OF CYCLIC AMP IN THE SUPERIOR CERVICAL GANGLION OF THE RAT

Toni Lindl

8 and Hinrich Cramer ~

FachbereichBiologie, University of Konstanz, D-775Konstanz,POB 7733

§

Neurologische Universit~tsklinikmitAbteilungftirNeurophysiologie D'78 Freiburg i.Br., Hansastr.

9

W.-Germany Received May 28,1975 SUMMARY. In isolated intact superior cervical ganglia of the rat dopamine is able to increase the levels of adenosine 3', 5'-monophosphate (cAMP) only if used in concentrations about two orders of magnitude higher than norepinephrine or epinephrine. The methylxanthines papaverine and theophylline have no or liminal effects on cAMP levels in control ganglia or ganglia incubated with dopamine. However, papaverine potentiates the norepinephrine-induced accumulation of cAMP both in ganglia and incubation media. Repeated incubations with norepinephrine in the presence of papaverine show a rapid decrement of the response and a sustained fall of cAMP in ganglia and media. The catecholamine induced rise was blocked by B-, and partially inhibited by ~-adrenergic antagonists. The role of adenosine 3', 5'-monophosphate

(cAMP)

in

the sympathetic peripheral nervous system has been the subject of numerous investigations in the past four years (I-8). It has been shown that electrical stimulation,

ca-

techolamines and histamine induce an accumulation of cAMP in the ganglia. Moreover,

evidence from experiments with

slices of bovine superior cervical ganglia and isolated intact rabbit ganglia has led to the suggestion that cAMP is involved in dopamine-mediated inhibition in the ganglion

(3,6). However, direct evidence that dopamine

alone causes an elevation of cAMP in the intact ganglion is as yet lacking;

in addition it is unclear whether the

Copyright © 1975 by Academic Press, Inc. All rights o f reproduction in any form reserved.

731

Vol. 65, No. 2, 1975

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

catecholamine-induced catecholaminergic

rise

in cAMP

inhibition

is c a u s a l l y

of t r a n s m i s s i o n

related

to

in the intact

ganglion. We p r e s e n t

evidence

that d o p a m i n e

10 -5 to 10 -3 M does not alter ganglia

of the rat,

a potent

increase medium

epinephrine agent,

was

both

another

abolished

causes

in g a n g l i a

potent

(9), is present.

and p a r t i a l l y

in

inhibitor.

in the c A M P - c o n t e n t

inhibitor

of

of t h e o p h y l l i n e ,

we show that n o r e p i n e p h r i n e

w h e n papaverine,

esterase

the c A M P - c o n c e n t r a t i o n

even in the p r e s e n c e

phosphodiesterase

Moreover,

in c o n c e n t r a t i o n s

and in the

cAMP-phosphodi-

The effect

by a B - a d r e n e r g i c

blocked

a large

of nor-

blocking

by an e - a d r e n e r g i c

blocking

agent.

M A T E R I A L S A N D METHODS. M a l e S p r a g u e - D a w l e y rats were k i l l e d by cervical d i s l o c a t i o n and the g a n g l i a w e r e r a p i d l y removed, desheathed, and kept on ice until used. I n c u b a t i o n p r o c e d u r e s w e r e e s s e n t i a l l y the same as d e s c r i b e d p r e v i o u s ly (5, 10). The cAMP c o n t e n t of g a n g l i a was d e t e r m i n e d acc o r d i n g to G i l m a n (11) after p u r i f i c a t i o n of e x t r a c t s on Dowex lX-2 columns (4). The i n c u b a t i o n m e d i a w e r e lyophilized, taken up in 50 m M acetate b u f f e r pH 4.0 and assayed for cAMP by the same method.

RESULTS

AND DISCUSSION.

10-3 M did not affect 10 -2 M c o n c e n t r a t i o n lation

Concentrations cAMP

did there

of the n u c l e o t i d e

(10-4 M)

and e p i n e p h r i n e

were m a x i m a l

(figure

Theophylline cant effect

levels

in ganglia,

appear

(10 -5 M)

up to

only at

a moderate

at a time w h e n

accumu-

norepinephrine

induced

increases

I).

(0.5 mM),

which

on the cAMP content,

alone was w i t h o u t was unable

the r e s p o n s e

to dopamine.

tion

by high c o n c e n t r a t i o n s

induced

of d o p a m i n e

The time course

732

signifi-

to p o t e n t i a t e

of the a c c u m u l a -

of d o p a m i n e

(10 -2 M)

Vol. 65, No. 2, 1975

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

T

.~±~ / /

,-i

S

z

~3

/ / / / / / /

iI

,.,4 ÷J

//-

,-4 /4 /4 ..4

~4 A

d IO-~M I04M CONTROL

Fi@ure

10-2}

DOPAMIN£

1:

E f f e c t of d o p a m i n e on levels of cyclic A M P in superior cervical g a n g l i a after five m i n u t e s of i n c u b a t i o n w i t h the amine in the m e d i u m at the c o n c e n t r a t i o n s indicated. H a t c h e d bars rep r e s e n t g a n g l i a i n c u b a t e d for 20 m i n in the p r e s e n c e of theop h y l l i n e (0.5 mM) p r i o r to the a d d i t i o n of d o p a m i n e (n = 4).

differed

notably

norepinephrine cAMP

f r o m that d e s c r i b e d

(4), and showed

concentrations

probably

represents

dopamine

rather

sensitive

has

little

(physical,

than

specific

(figure

required,

and indirect

activation

however,

of

2). the effect

actions

of

of a d o p a m i n e -

that e x o g e n o u s

on the c A M P - c o n t e n t

metabolic,

ing the receptors.

increase

and

cyclase.

be ruled out,

effect

30 m i n

concentration

non-specific

adenylate

It c a n n o t

a sustained

for at least

In v i e w of the h i g h

for e p i n e p h r i n e

uptake)

prevent

because dopamine

But e l e c t r o p h y s i o l o g i c a l

733

dopamine

barriers f r o m reach-

experiments

of

Vol. 65, No. 2, 1975

BIOCHEMICALAND BIOPHYSICAL RESEARCH COMMUNICATIONS

4

3 u4

2

I

1'0

6

2'0

3'0

TIME (MIN)

Figure

2:

Time course of a c c u m u l a t i o n of cAMP in f r e s h l y d i s s e c t e d g a n g l i a on i n c u b a t i o n w i t h d o p a m i n e (10 -2 M). (n = 4) * * s i g n i f i c a n t l y d i f f e r e n t f r o m controls, p ~ O . O 5 s i g n i f i c a n t l y d i f f e r e n t from controls, p-=~O.O2

McAfee cause

and G r e e n g a r d

(12)

hyperpolarization

or cervical penetrate

ganglion

of CAMP

Papaverine ganglia

cells

which

in rat superior

with papaverine lation

were

cyclic AMP

of p o s t g a n g l i o n i c of the rabbit

dopamine

neurons

does

of superi-

and hence

does

into the ganglia.

Norepinephrine, cyclase

show that e x o g e n o u s

is a p o t e n t cervical

(10 -4 M) caused in g a n g l i a

alone

ganglia a more

(figure

did not affect

incubated

with

from the tissue

activator (4),

of a d e n y l a t e in c o m b i n a t i o n

than a d d i t i v e

accumu-

3). the c A M P - c o n t e n t

it for 6 minutes.

when

Release

of

into the m e d i u m was also en-

734

Vol. 65, No. 2, 1975

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

[ i

40

,

I

, J.

O m

o

30

4.!

g, I L

~

Ik

20

a

lO

CON NE

NE

CON N E

NE + PAP

t-

Fi@ure

PAP

3:

C o n c e n t r a t i o n of cAMP in g a n g l i a after the first and the fourth of a series of s t i m u l a t i o n w i t h n o r e p i n e p h r i n e (NE, 10 -4 M) or n o r e p i n e p h r i n e + p a p a v e r i n e (PAP, 10 -4 M). G a n g l i a w e r e i n c u b a t e d for 15 m i n in the p r e s e n c e of the drugs between i n c u b a t i o n p e r i o d s of 20 m i n in d r u g - f r e e m e d i u m (n = 6). ~p
hanced when ganglia epinephrine verine

incubated

or in the p r e s e n c e

(figure

On r e p e a t e d drug-free

were

incubations

fell

after

near

the d e t e c t i o n

second

with alternating

medium,

the cyclic

incubation

limit

fall was only d e t e c t a b l e the c o m b i n a t i o n

of n o r e p i n e p h r i n e

of nor-

and papa-

4).

incubation the

in the p r e s e n c e

after

period

nucleotide

were

norepinephrine/papaverine.

735

with content

and r e a c h e d

the fourth

when ganglia

washes

values

incubation. incubated

The with

No s i g n i f i c a n t

Vol. 65, No. 2, 1975

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

W

Z

o z

3.0

~9

÷i

~

20

n

1.o

1

2

3

4

Fi@ure 4: Release of cyclic AMP into the incubation m e d i u m after sequential s t i m u l a t i o n of ganglia w i t h n o r e p i n e p h r i n e J 'J or n o r e p i n e p h r i n e + p a p a v e r i n e 177"]. S t i m u l a t i o n period: 15 min w i t h an a d d i t i o n a l w a s h i n g p e r i o d of 20 min. C o n c e n t r a t i o n of norepinephrine: 10 -4 M; papaverine: 10 -4 M (n = 6 + S.D.). ~ = control. N u m b e r s under the bars r e p r e s e n t the p e r i o d of stimulation.

changes were o b s e r v e d during control incubations with norepinephrine entire i n c u b a t i o n

period,

the cyclic n u c l e o t i d e

content of

alone was still ele-

, w h i l e the cAMP content of ganglia

norepinephrine/papaverine

and during

alone. A t the end of the

the ganglia exposed to n o r e p i n e p h r i n e vated

incubations

incubated with

was b e l o w the control values

(figure 3). A decrease stimulations

in the cAMP c o n c e n t r a t i o n of adenylate

in b r a i n slices

after sequential

cyclase has also been o b s e r v e d

(13). The a p p a r e n t

736

refractoriness

of the

Vol. 65, No. 2, 1975

BIOCHEMICALAND BIOPHYSICAL RESEARCH COMMUNICATIONS

adenylate cyclase to the catecholamine may be due to the exhaustion of a limited pool of ATP, the substrate of adenylate cyclase, within the membrane compartment

(14-16).

A limited supply of ATP can also explain the observation that the rate of conversion of radioactive adenine into cAMP in the ganglion during electrical stimulation falls rapidly with increasing frequency, 2400 pulses were given

or when more than

(17).

Pharmacological evidence from previous studies

(4, 6)

led to the conclusion that two types of catecholamine receptors, alpha and beta, can lead to elevations in cAMP in the peripheral nervous system, and that dopamine activates adenylate cyclase by a mechanism involving an ~adrenoceptor. In the rat superior cervical ganglion however,

alpha

adrenergic agents such as dopamine and phenylephrine in reasonable concentrations were without effect on the concentration of cAMP in the ganglion

(2,4). Preincubation

with 10 -5 M propranolol abolished the norepinephrine-induced rise of cyclic AMP, but 10 -5 M phentolamine inhibited the rise by only 50%

(figure 5).

These observations can be interpreted as indicating that both types of receptors may be present in the ganglia but that B-receptors for adenylate cyclase prevail in this species while dopamine does not activate the enzyme. Moreover,

it was described recently that propranolol has an

ID 50 of 2.2 x 10 -7 M suggesting nonspecific effects of 10 -5 M phentolamine

(10).

The present experiments

in rat superior cervical ganglia

737

Vol. 65, No. 2, 1975

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Z

O

30

.J

C~

**

z

4-1

20

0

~

~

10 u

CON

NE

PHE

NF +

PHA

Figure 5:

NE -t-

PROP

Effects of norepinephrine (NE, 10 -4 M) and phenylephrine (PHE, 10 -2 M) on cyclic AMP levels in ganglia and effects of phentolamine (PHA, 10 -5 M) and propramolol (PROP, 10 -5 M) on the accumulation of cyclic AMP in ganglia induced by norepinephrine (10 -4 M) (n = 6). ~p~O.O1; ~ p~O.OO1 significance of difference from controls.

fail to support the concept of a "dopamine-sensitive late cyclase"

(8) which supposedly mediates

hibitory postsynaptic

potential

(sIPSP)

From this and other investigations gested that,

adeny-

the slow in-

in the ganglion. (4,7)

it can be sug-

if cyclic AMP is actually linked with slow in-

hibitory postsynaptic

potential

(sIPSP), norepinephrine

is

more likely to be responsible

for this action because of its

marked potency in stimulating

adenylate cyclase and its known

capacity to influence transmission

through the ganglion.

Acknowledgement: This work was supported by the Deutsche Forschungsgemeinschaft (SFB 70 and SFB 138). REFERENCES I.

McAfee, D.A., Schorderet, M., and Greengard, Science 171, 1156-1158 (1971)

738

P.

Vol. 65, No. 2, 1975

2 3 4 5 6 7 8 9 10. II. 12. 13. 14. 15. 16. 17.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cramer, H., Johnson, D.G., Silberstein, S.D., and Kopin, I.J. Pharmacologist 13, 257 (1971) Kebabian, J.W., and Greengard, P. Science 174, 1346-1349 (1971) Cramer, H., Johnson, D.G., Hanbauer, I., Silberstein, S.D., and Kopin, I.J. Brain Res. 53, 97-104 (1973) Lindl, T., and Cramer, H. Biochim. Biophys. Acta 343, 182-191 (1974) Kalix, P., McAfee, D.A., Schorderet, M., and Greengard, P. J.Pharmacol. and Exp.Therap. 188, 676-687 (1974) Otten, U., Mueller, R.A., Oesch, F., and Thoenen, H. Proc. Nat. Acad. Sci. USA 71, 2217-2221 (1974) Greengard, P., and Kebabian, J.W. Fed. Proc. 33, 1059-1067 (1974) Schultz, J., and Daly, J.W. J.Biol.Chem. 248, 853-859 (1973) Lindl, T., Behrendt, H., Heinl-Sawaya, M.C.B., Teufel,E., and Cramer, H. Naun. Schm.Arch.Pharmacol. 286, 283-296 (1974) Gilman, A.G. Proc. Nat. Acad. Sci. USA 67, 305-312 (1970) McAfee, D.A., and Greengard, P. Science 178, 310-312 (1972) Schultz, J., and Daly, J.W. J.Biol.Chem. 248, 860-866 (1973) Reporter, M. Biochem. Biophys. Res. Comm. 48, 598-604 (1972) Shimizu, H., and Okayama, H. J.Neurochem. 20, 1279-1283 (1973) Lindl, T., Heinl-Sawaya, M.C.B., and Cramer, H. Biochem. Pharmacol. 24, 947-950 (1975) Chatzkel, S., Zimmerman, I., and Berg, A. Brain Res. 80, 523-526 (1974)

739